Search

The former director of the Oregon Health Authority says he's taking life easy and any rumors about his succession plan are unfounded.

The American Association for the Study of Liver Diseases recommends that Sovaldi be used with patients with late-stage liver disease, but state bureaucrats were ready to block coverage for all patients because of the high price tag of the drug and a report from OHSU’s Center for Evidence-Based Policy that raised red flags about the drug’s studies, helping the state in its attempt to get out of paying for treatment.

The state senator told Healthcare for All Oregon that a single-payer bill will need bipartisan support in the Oregon Legislature.

Among the private insurers, Regence BlueCross BlueShield is the lowest payer and reduced its rates over the past two year, while a new contract is under negotiation.